Bicycletx Limited

This early-stage study is testing a new drug called BT8009 in people with advanced solid tumors that have a specific marker called Nectin-4. The main goals are to find a safe dose, see how the body processes the drug, and get a first look at whether it can shrink tumors. The drug…

This early-stage study is testing a new drug called BT7480, both by itself and combined with an existing immunotherapy (nivolumab), in people with advanced solid tumors. The main goals are to find the safest and most effective dose and to learn about the drug's side effects and h…

This early-stage study is testing a new drug called BT5528 in people with advanced solid tumors that have spread or returned. The main goals are to find a safe dose, understand the side effects, and see if the drug shows early signs of helping to control cancers like ovarian, lun…